Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NTNU Technology Transfer AS (NTNU TTO) is the commercialization arm of the Norwegian University of Science and Technology and the Central Norway Regional Health Authority. The organization identifies, evaluates, and develops research-based innovations with commercial potential, specializing in intellectual property management, licensing, and the creation of spin-off companies. In the life sciences sector, NTNU TTO manages a diverse portfolio of technologies ranging from novel therapeutic modalities and diagnostics to advanced medical devices. They provide researchers with business development expertise, seed funding through the NTNU Discovery program, and access to an extensive international network of investors and industry partners. Notable life science spin-offs from their portfolio include APIM Therapeutics, Vectron Biosolutions, and Serca Pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NTNU Technology Transfer.